Search research articles
Contact Us
Filters
Showing results (21-30 of 200) with videos related to
Page
of 20
Sort By:
Advances in Cancer Research
|
August 1, 2018
Targeting Sphingosine Kinases for the Treatment of Cancer
Clayton S Lewis, Christina Voelkel-Johnson, Charles D Smith
Oncotarget
|
August 13, 2016
Suppression of c-Myc and RRM2 expression in pancreatic cancer cells by the sphingosine kinase-2 inhibitor ABC294640
Clayton S Lewis, Christina Voelkel-Johnson, Charles D Smith
Investigational New Drugs
|
May 18, 2010
Combined anticancer effects of sphingosine kinase inhibitors and sorafenib
Vladimir Beljanski, Christian Knaak, Yan Zhuang, et al.
Journal of the American Academy of Dermatology
|
July 6, 2010
Giant fibrous hamartoma of infancy: a report of two cases and review of the literature
Joseph McGowan, Charles D Smith, John Maize, et al.
Neurology
|
October 13, 2006
Homonymous hemianopsia complicating treatment of postoperative epistaxis
Patricio S Espinosa, Charles D Smith, Joseph R Berger
Journal of Medicinal Chemistry
|
June 15, 2007
Discovery of novel antitumor antimitotic agents that also reverse tumor resistance
Aleem Gangjee, Jianming Yu, Jean E Copper, et al.
The Nursing Clinics of North America
|
August 5, 2008
African Americans with memory loss: findings from a community clinic in Lexington, Kentucky
Deborah D Danner, Charles D Smith, Peace Jessa, et al.
Journal of the South Carolina Medical Association (1975)
|
April 20, 2005
Thermal injury in children
Jana E Upshaw, Charles D Smith, Edward P Tagge, et al.
Bioorganic & Medicinal Chemistry
|
June 18, 2011
2-Amino-4-methyl-5-phenylethyl substituted-7-N-benzyl-pyrrolo[2,3-d]pyrimidines as novel antitumor antimitotic agents that also reverse tumor resistance
Aleem Gangjee, Ojas A Namjoshi, Staci N Keller, et al.
Pharmacology
|
February 25, 2011
Experimental osteoarthritis in rats is attenuated by ABC294640, a selective inhibitor of sphingosine kinase-2
Leo R Fitzpatrick, Cecelia Green, Lynn W Maines, et al.
Page
of 20
Search research articles
Search
Showing results (21-30 of 200) with videos related to
Sort By:
Page
of 20
Advances in Cancer Research
|
August 1, 2018
Targeting Sphingosine Kinases for the Treatment of Cancer
Clayton S Lewis, Christina Voelkel-Johnson, Charles D Smith
Oncotarget
|
August 13, 2016
Suppression of c-Myc and RRM2 expression in pancreatic cancer cells by the sphingosine kinase-2 inhibitor ABC294640
Clayton S Lewis, Christina Voelkel-Johnson, Charles D Smith
Investigational New Drugs
|
May 18, 2010
Combined anticancer effects of sphingosine kinase inhibitors and sorafenib
Vladimir Beljanski, Christian Knaak, Yan Zhuang, et al.
Journal of the American Academy of Dermatology
|
July 6, 2010
Giant fibrous hamartoma of infancy: a report of two cases and review of the literature
Joseph McGowan, Charles D Smith, John Maize, et al.
Neurology
|
October 13, 2006
Homonymous hemianopsia complicating treatment of postoperative epistaxis
Patricio S Espinosa, Charles D Smith, Joseph R Berger
Journal of Medicinal Chemistry
|
June 15, 2007
Discovery of novel antitumor antimitotic agents that also reverse tumor resistance
Aleem Gangjee, Jianming Yu, Jean E Copper, et al.
The Nursing Clinics of North America
|
August 5, 2008
African Americans with memory loss: findings from a community clinic in Lexington, Kentucky
Deborah D Danner, Charles D Smith, Peace Jessa, et al.
Journal of the South Carolina Medical Association (1975)
|
April 20, 2005
Thermal injury in children
Jana E Upshaw, Charles D Smith, Edward P Tagge, et al.
Bioorganic & Medicinal Chemistry
|
June 18, 2011
2-Amino-4-methyl-5-phenylethyl substituted-7-N-benzyl-pyrrolo[2,3-d]pyrimidines as novel antitumor antimitotic agents that also reverse tumor resistance
Aleem Gangjee, Ojas A Namjoshi, Staci N Keller, et al.
Pharmacology
|
February 25, 2011
Experimental osteoarthritis in rats is attenuated by ABC294640, a selective inhibitor of sphingosine kinase-2
Leo R Fitzpatrick, Cecelia Green, Lynn W Maines, et al.
Page
of 20